• LAST PRICE
    0.8093
  • TODAY'S CHANGE (%)
    Trending Down-0.0007 (-0.0864%)
  • Bid / Lots
    0.7902/ 1
  • Ask / Lots
    0.8250/ 1
  • Open / Previous Close
    0.8100 / 0.8100
  • Day Range
    Low 0.7901
    High 0.8100
  • 52 Week Range
    Low 0.6130
    High 13.0000
  • Volume
    22,057
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.81
TimeVolumePTE
09:32 ET1060.81
09:35 ET25010.8021
09:37 ET9920.80605
09:42 ET1000.802
09:46 ET14000.806049
09:48 ET10000.806049
10:08 ET1270.806051
10:33 ET28040.8022
10:44 ET1000.8022
10:45 ET10000.8022
10:47 ET29320.7903
11:59 ET6800.8073
12:08 ET1000.805
12:21 ET1000.8001
12:24 ET11960.7923
12:26 ET3500.8
12:28 ET13580.7903
12:51 ET2000.799
01:18 ET15000.8056
01:27 ET9000.81
01:31 ET1000.809899
02:05 ET2430.790101
02:16 ET1000.8
03:39 ET1000.809299
03:53 ET2000.8093
03:57 ET2070.8093
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPTE
PolarityTE Inc
5.9M
-0.2x
---
United StatesNBY
NovaBay Pharmaceuticals Inc
4.6M
-0.4x
---
United StatesPTPI
Petros Pharmaceuticals Inc
5.8M
-1.9x
---
United StatesROSGQ
Rosetta Genomics Ltd
590.0
0.0x
---
United StatesEPGNY
Epigenomics AG
6.5M
0.0x
---
United StatesPHASQ
PhaseBio Pharmaceuticals Inc
737.9K
0.0x
---
As of 2023-02-07

Company Information

PolarityTE, Inc. is a biotechnology company. The Company is focused on developing regenerative tissue products and biomaterials. It also operates a laboratory testing and clinical research business using equipment, personnel, and facilities it acquired to advance its development of regenerative tissue products. Its first regenerative tissue product is SkinTE, which is intended for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The Company's development projects include SkinTE Cryo, SkinTE point-of-care device, PTE 11000, and others.

Contact Information

Headquarters
1960 S. 4250 WestSALT LAKE CITY, UT, United States 84104
Phone
385-266-3151
Fax
302-636-5454

Executives

Independent Chairman of the Board
Peter Cohen
President, Chief Executive Officer
Richard Hague
Interim Chief Financial Officer
Jacob Patterson
Executive Vice President - Corporate Development & Strategy, General Counsel
Cameron Hoyler
Director
Jeff Dyer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.9M
Revenue (TTM)
$1.9M
Shares Outstanding
7.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.22
EPS
$-4.22
Book Value
$5.83
P/E Ratio
-0.2x
Price/Sales (TTM)
3.2
Price/Cash Flow (TTM)
---
Operating Margin
-1,640.46%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.